Volume 54; Issue 5

Cancer Immunology, Immunotherapy

Volume 54; Issue 5

1

Comparison of antigen constructs and carrier molecules for augmenting the immunogenicity of the monosaccharide epithelial cancer antigen Tn

Ella Kagan, Govind Ragupathi, San San Yi, Celso A. Reis, Jeff Gildersleeve, Daniel Kahne, Henrik Clausen, Samuel J. Danishefsky, Philip O. Livingston

Journal:

Cancer Immunology, Immunotherapy

Year:

2005

Language:

english

File:

PDF, 333 KB

english, 2005

2

Induction of specific human primary immune responses to a Semliki Forest virus–based tumor vaccine in a Trimera mouse model

Bing Ni, Wenda Gao, Bo Zhu, Zhihua Lin, Zhengcai Jia, Wei Zhou, Jianping Zhao, Li Wang, Yuzhang Wu

Journal:

Cancer Immunology, Immunotherapy

Year:

2005

Language:

english

File:

PDF, 614 KB

english, 2005

3

Reduction of the antiapoptotic protein cFLIP enhances the susceptibility of human renal cancer cells to TRAIL apoptosis

Alan D. Brooks, Thomas J. Sayers

Journal:

Cancer Immunology, Immunotherapy

Year:

2005

Language:

english

File:

PDF, 342 KB

english, 2005

4

Harnessing host immune responses to preneoplasia: promise and challenges

Madhav V. Dhodapkar

Journal:

Cancer Immunology, Immunotherapy

Year:

2005

Language:

english

File:

PDF, 166 KB

english, 2005

5

Tumor sensitivity to IFN-γ is required for successful antigen-specific immunotherapy of a transplantable mouse tumor model for HPV-transformed tumors

Mary E. Dominiecki, Gregory L. Beatty, Zhen-Kun Pan, Paul Neeson, Yvonne Paterson

Journal:

Cancer Immunology, Immunotherapy

Year:

2005

Language:

english

File:

PDF, 638 KB

english, 2005

6

Epithelial tight junction proteins as potential antibody targets for pancarcinoma therapy

Sonja Offner, Armin Hekele, Ulrike Teichmann, Susanne Weinberger, Susanne Gross, Peter Kufer, Christian Itin, Patrick A. Baeuerle, Birgit Kohleisen

Journal:

Cancer Immunology, Immunotherapy

Year:

2005

Language:

english

File:

PDF, 1.83 MB

english, 2005

7

A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr)

Ralf G. Meyer, Cedrik M. Britten, Ulrike Siepmann, Barbara Petzold, Tolga A. Sagban, Hans A. Lehr, Bernd Weigle, Marc Schmitz, Luis Mateo, Burkhard Schmidt, Helga Bernhard, Thilo Jakob, Rüdiger Hein,

Journal:

Cancer Immunology, Immunotherapy

Year:

2005

Language:

english

File:

PDF, 495 KB

english, 2005

8

Paclitaxel probably enhances cytotoxicity of natural killer cells against breast carcinoma cells by increasing perforin production

Makoto Kubo, Takashi Morisaki, Kotaro Matsumoto, Akira Tasaki, Naoki Yamanaka, Hiroshi Nakashima, Hideo Kuroki, Katsuya Nakamura, Masafumi Nakamura, Mitsuo Katano

Journal:

Cancer Immunology, Immunotherapy

Year:

2005

Language:

english

File:

PDF, 487 KB

english, 2005

9

Effective induction of antitumor immunity by immunization with plasmid DNA encoding TRP-2 plus neutralization of TGF-β

Zheng-Cai Jia, Li-Yun Zou, Bing Ni, Ying Wan, Wei Zhou, Yan-Bo Lv, Miao Geng, Yu-Zhang Wu

Journal:

Cancer Immunology, Immunotherapy

Year:

2005

Language:

english

File:

PDF, 278 KB

english, 2005

10

Immunotherapy for superficial bladder cancer

Ellen A. M. Schenk-Braat, Chris H. Bangma

Journal:

Cancer Immunology, Immunotherapy

Year:

2005

Language:

english

File:

PDF, 251 KB

english, 2005

11

In vitro dendritic cell generation and lymphocyte subsets in myeloma patients: influence of thalidomide and high-dose chemotherapy treatment

Philipp Schütt, Ulrike Buttkereit, Dieter Brandhorst, Monika Lindemann, Sven Schmiedl, Hans Grosse-Wilde, Siegfried Seeber, Mohammad Resa Nowrousian, Bertram Opalka, Thomas Moritz

Journal:

Cancer Immunology, Immunotherapy

Year:

2005

Language:

english

File:

PDF, 249 KB

english, 2005